In 2006, phase I trials of the drug TGN1412 had to be suspended when previously healthy volunteers developed multiple organ failure, with some barely escaping death. University College London pharmacologist Trevor Smart believes that they may never fully recover.
2006年，新药TGN1412的I期试验被迫暂停，因为本来健康的志愿者表现出多器官功能衰竭，有些人将将逃过一死。伦敦学院药理学家特雷佛·斯马特认为很多受试者可能永远无法彻底康复。